Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Xiaofang Bian
Special MTA: None
ATGTCGATGACGGCCTCGTCATCCACGCCGCGGCCCACGCCCAAGTACGACGACGCCTTG
ATCCTCAACCTCTCGTCGGCCGCCAAGATCGAACGGATCGTCGACAAGGTCAAGTCCCTC
TCGCGCGAGCGCTTTGCGCCCGAGGATTTTTCGTTCCAGTGGTTTCGCTCCATCAGTCGC
GTTGAACGAACGACAGATAACAACCCCTCTGCCGCAACTACCACCGCGGCAACGGCGACC
GTTCACTCCTCCGCCTCCTCTTCTGCCGCCGCTGCCGCTTCGTCCGAGGCCGGCGGCACG
CGCGTGCCCTGCGTCGACCGTTGGCCCTTCTTTCCCTTCCGCGCGCTGCTCGTCACCGGC
ACGGCGGGCGCCGGCAAGACTTCCAGCATCCAGGTGCTGGCGGCCAATCTAGATTGCGTG
ATCACCGGTACCACGGTGATCGCCGCGCAGAACCTCAGCGCGATCCTCAACCGCACTCGC
TCGGCGCAGGTCAAGACCATCTACCGCGTCTTCGGCTTCGTCAGCAAGCACGTGCCGCTG
GCTGACAGCGCCGTTAGCCACGAGACGCTGGAACGCTACCGCGTGTGCGAGCCGCACGAG
GAGACCACCATCCAGCGCCTGCAGATCAACGATCTGCTCGCCTACTGGCCGGTCATCGCC
GACATCGTGGACAAATGCTTAAATATGTGGGAGCGCAAGGCCGCTTCGGCCTCCGCCGCG
GCCGCGGCCGCCGCCTGCGAGGACCTCTCGGAGCTGTGCGAGAGCAATATCATCGTCATC
GACGAGTGCGGCCTTATGCTGCGCTACATGCTGCAGGTGGTGGTGTTTTTTTACTACTTT
TACAACGCCCTGGGCGACACGCGACTTTACCGCGAACGCCGCGTGCCCTGCATCATCTGC
GTCGGTTCGCCCACGCAGACCGAGGCGCTGGAGAGCCGCTACGACCACTACACGCAAAAC
AAGAGCGTGCGCAAGGGCGTTGACGTGCTCTCGGCGCTGATTCAGAACGAAGTGCTCATC
AACTACTGCGACATCGCCGACAACTGGGTCATGTTTATTCACAACAAGCGTTGCACCGAC
CTGGACTTTGGCGACCTGCTCAAGTACATGGAGTTCGGTATCCCGCTCAAGGAAGAGCAC
GTGGCCTACGTGGACCGCTTCGTGCGGCCGCCCAGCTCCATCCGCAATCCCTCGTACGCC
GCCGAGATGACGCGGCTTTTTCTCTCGCACGTCGAGGTGCAGGCTTACTTCAAGCGGCTG
CACGAGCAGATCCGCCTGAGCGAGCGCCACCGTCTCTTTGATTTGCCCGTCTACTGCGTG
GTCAACAACCGCGCGTACCAGGAGCTCTGCGAGCTGGCCGACCCGCTGGGCGACTCGCCG
CAGCCCGTCGAGCTCTGGTTCCGCCAGAACTTGGCGCGCATCATTAACTACTCGCAGTTT
GTCGACCACAACCTCTCCAGCGAGATCACCAAGGAGGCGCTGCGCCCCGCGGCCGACGTC
GTTGCCACCAACAACCCCTCCGTCCAGGCTCACGGAGGGGGAGGATCTGTAATCGGGAGC
ACCGGCGGCAACGACGAGACGGCGTTTTTCCAGGACGATGATACCACCACCGCGCCCGAT
AGCCGTGAGACGCTGCTCACCTTGCGCATTACCTACATCAAGGGCAGTTCGGTGGGAGTC
AACTCTAAGGTGCGGGCCTGTGTTATCGGATACCAGGGCACGGTCGAACGTTTCGTGGAC
ATCTTGCAAAAGGACACGTTTATCGAACGCACGCCCTGCGAGCAGGCGGCCTACGCCTAC
TCGTTAGTTTCGGGCCTGCTCTTCTCGGCCATGTACTACTTTTACGTGTCGCCCTACACG
ACCGAGGAGATGTTGCGTGAGCTGGCGCGCGTTGAGCTGCCCGACGTGAGTTCGCTCTGC
GCCGCTGCCGCCGCCACGGCCGCCGCTCCCGCTTGGAGCGGGGGAGAGAATCCGATAAAT
AATCACGTCGACGCGGATTCTTCTCAGGGCGGCCAGAGCGTGCCGGTATCTCAACGGATG
GAACATGGCCAAGAGGAGACCCACGACATCCCCTGCCTGTCCAACCACCATGACGACTCG
GACGCCATCACGGACGCCGAACTCATGGATCACACCAGTCTGTACGCGGATCCCTTTTTT
CTCAAATACGTCAAGCCACCTAGCCTGGCGCTGCTTTCTTTCGAGGAGACGGTGCACATG
TACACTACCTTCCGCGACATTTTTCTCAAGCGCTACCAGCTCATGCAGCGTCTCACGGGC
GGTCGCTTCGCCACGTTGCCGCTCGTTACCTACAATCGCCGTAACGTGGTGTTCAAGGCC
AACTGTCAGATCAGCTCGCAGACCGGCTCCTTCGTGGGCATGCTTTCGCATGTGTCGCCG
GCGCAGACGTACACGCTCGAGGGCTACACCAGCGACAACGTGCTCAGTCTGCCCAGTGAC
CGCCACCGCATCCACCCCGAGGTGGTGCAGCGCGGTCTTTCGCGGCTGGTGCTACGCGAT
GCGCTCGGGTTCCTCTTTGTGCTCGACGTTAACGTCTCGCGCTTCGTCGAGTCGGCGCAG
GGCAAGAGTCTGCACGTGTGCACCACCGTGGACTACGGCCTCACTTCGCGCACGGCCATG
ACCATCGCCAAGAGTCAGGGCCTGTCGCTCGAGAAGGTGGCCGTGGACTTTGGGGACCAT
CCCAAGAACCTCAAGATGAGCCACATCTACGTGGCCATGTCGCGAGTCACGGACCCCGAG
CACCTCATGATGAACGTCAACCCGTTGCGACTTCCCTATGAGAAGAACACCGCTATCACC
CCCTATATCTGTCGCGCGCTCAAAGACAAACGCACCACGCTTATTTTT
MSMTASSSTPRPTPKYDDALILNLSSAAKIERIVDKVKSLSRERFAPEDFSFQWFRSISR VERTTDNNPSAATTTAATATVHSSASSSAAAAASSEAGGTRVPCVDRWPFFPFRALLVTG TAGAGKTSSIQVLAANLDCVITGTTVIAAQNLSAILNRTRSAQVKTIYRVFGFVSKHVPL ADSAVSHETLERYRVCEPHEETTIQRLQINDLLAYWPVIADIVDKCLNMWERKAASASAA AAAAACEDLSELCESNIIVIDECGLMLRYMLQVVVFFYYFYNALGDTRLYRERRVPCIIC VGSPTQTEALESRYDHYTQNKSVRKGVDVLSALIQNEVLINYCDIADNWVMFIHNKRCTD LDFGDLLKYMEFGIPLKEEHVAYVDRFVRPPSSIRNPSYAAEMTRLFLSHVEVQAYFKRL HEQIRLSERHRLFDLPVYCVVNNRAYQELCELADPLGDSPQPVELWFRQNLARIINYSQF VDHNLSSEITKEALRPAADVVATNNPSVQAHGGGGSVIGSTGGNDETAFFQDDDTTTAPD SRETLLTLRITYIKGSSVGVNSKVRACVIGYQGTVERFVDILQKDTFIERTPCEQAAYAY SLVSGLLFSAMYYFYVSPYTTEEMLRELARVELPDVSSLCAAAAATAAAPAWSGGENPIN NHVDADSSQGGQSVPVSQRMEHGQEETHDIPCLSNHHDDSDAITDAELMDHTSLYADPFF LKYVKPPSLALLSFEETVHMYTTFRDIFLKRYQLMQRLTGGRFATLPLVTYNRRNVVFKA NCQISSQTGSFVGMLSHVSPAQTYTLEGYTSDNVLSLPSDRHRIHPEVVQRGLSRLVLRD ALGFLFVLDVNVSRFVESAQGKSLHVCTTVDYGLTSRTAMTIAKSQGLSLEKVAVDFGDH PKNLKMSHIYVAMSRVTDPEHLMMNVNPLRLPYEKNTAITPYICRALKDKRTTLIF
Coding Sequence Details
Recommended Growth Condition: